Sales and Marketing

Showing 15 posts of 11528 posts found.

Anti-vaxxers: Vaccines in the age of populism

November 6, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing anti vaccine, anti-vaccine, history, medicine, populism, vaccines

Mistrust of the establishment has fuelled anti-vaccine sentiment in recent years, and adherence has waned as a result. Louis Goss …

FDA controversially approves potent opioid up to ten times stronger than fentanyl

November 6, 2018 Sales and Marketing Dsuvia, FDA, US, fentanyl, opioid crisis, opioids, pharma

Despite voices of criticism, the FDA has opted to approve AcelRX’s Dsuvia (sufentanil), an opioid medication said to be five …

Top Ten most popular articles on Pharmafile.com this week!

November 2, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, GSK, ITH Pharma, J&J, JJ, NICE, Sanofi, Trump, top 10

Deals dominated the headlines this week as both Sanofi and AstraZeneca made billion dollar agreements. Meanwhile, the FDA gave magic …

Committee advises against FDA approval of Alkermes’ novel depression drug

November 2, 2018 Medical Communications, Sales and Marketing Alkermes, FDA, depression, pharma

Alkermes has been knocked back with the disappointing, though not entirely unexpected, news that the FDA-appointed Psychopharmacologic Drugs Advisory Committee …

Galectin-3: The protein paving new treatment avenues

November 1, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Galectin-3, Galectins, breast cancer, diabetes, heart disease, pharma

Matthew Blakeley, LADI-III Beamline Scientist at Institut Laue-Langevin (ILL) and Derek Logan, Associate Professor in Structural Biology at Lund University, …

Sanofi teams up with Denali in $1.125bn neurological and inflammatory development deal

November 1, 2018 Research and Development, Sales and Marketing Denali Therapeutics, Sanofi, pharma

Sanofi has sealed the deal with Denali Therapeutics to leverage the latter’s small molecule candidates in the development of new …

MSD’s Keytruda/chemo combo scores first-line FDA approval in NSC lung cancer

November 1, 2018 Sales and Marketing Cancer, MSD, NSCLC, keytruda, lung cancer, pharma

MSD’s blockbuster anti-PD-1 immunotherapy has secured another FDA approval, it has emerged, in combination with carboplatin and either paclitaxel or …

AstraZeneca flogs two drug licenses in $922 million deal

October 31, 2018 Research and Development, Sales and Marketing AstraZeneca, pharma

AstraZeneca has signed a deal with Grünenthal worth up to $922 million in which the latter will acquire the regional …

J&J’s Invokana becomes first FDA-approved oral diabetes drug to reduce cardiovascular event risk

October 31, 2018 Research and Development, Sales and Marketing FDA, J&J, JJ, invokana, pharma

The FDA has given the go-ahead for Johnson & Johnson’s drug Invokana (canagliflozin) for use in the risk reduction of …

NICE turns down Sanofi’s Caprelsa for rare thyroid cancer

October 31, 2018 Research and Development, Sales and Marketing Cancer, Caprelsa, NHS, NICE, Sanofi, UK, medullary thyroid cancer, pharma

NICE has announced its recommendation to reject Sanofi’s Caprelsa (vandetanib) for use on the NHS in the treatment of medullary …

Effective preventative therapies for type 2 diabetes are underused, new research argues

October 30, 2018 Manufacturing and Production, Research and Development, Sales and Marketing diabetes, obesity, pharma, prediabetes, type 2 diabetes

New research has warned that interventions which can effectively delay or prevent the development of type 2 diabetes are not …

Not so crystal clear: The EU’s clinical reporting problem

October 29, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EBM Datalabs, clinical trial transparency, clinical trials, feature, pharma, transparency

With shocking new findings revealing that around half of all clinical trial results in Europe go unreported, Matt Fellows explores …

US court overturns J&J’s Zytiga patent in combination with prednisone

October 29, 2018 Sales and Marketing J&J, JJ, Johnson and Johnson, Zytiga, court, generic, prednisone

A court in New Jersey has invalidated Johnson & Johnson’s patent on the prostate cancer drug Zytiga when used in …

Roche’s eye drug beats Lucentis at Phase 2 in wet age-related macular degeneration

October 29, 2018 Research and Development, Sales and Marketing Genentech, Lucentis, Roche, eyecare, faricimab, pharma

Roche has revealed positive new Phase 2 data for faricimab (RG7716) in the treatment of neovascular (“wet”) age-related macular degeneration …

Vaccine coverage falls by 6.2% since last year

October 29, 2018 Sales and Marketing CDC, flu, influenza, vaccine coverage, vaccines

Despite the severity of the flu season, just 37.1% of American adults received the flu vaccine this year, according to …
The Gateway to Local Adoption Series

Latest content